Revealing mechanistic insights into the drug-induced disruption of the hepatitis B virus capsid through the computational microscope

Jodi Hadden, University of Delaware

Usage Details

The allocation will be used to study the effects of drugs on the hepatitis B virus capsid.
There is currently no cure for hepatitis B virus, but disruption of the its capsid, which drives delivery of the viral genome to the host cell nucleus, represents a promising approach for new antiviral treatments.